ES515766A0 - Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol. - Google Patents

Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol.

Info

Publication number
ES515766A0
ES515766A0 ES515766A ES515766A ES515766A0 ES 515766 A0 ES515766 A0 ES 515766A0 ES 515766 A ES515766 A ES 515766A ES 515766 A ES515766 A ES 515766A ES 515766 A0 ES515766 A0 ES 515766A0
Authority
ES
Spain
Prior art keywords
mercaptoimidazole
procedure
obtaining
new derivatives
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES515766A
Other languages
English (en)
Other versions
ES8403877A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES515766A0 publication Critical patent/ES515766A0/es
Publication of ES8403877A1 publication Critical patent/ES8403877A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES515766A 1978-04-11 1982-09-16 Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol. Expired ES8403877A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU79412 1978-04-11

Publications (2)

Publication Number Publication Date
ES515766A0 true ES515766A0 (es) 1984-04-01
ES8403877A1 ES8403877A1 (es) 1984-04-01

Family

ID=19728887

Family Applications (5)

Application Number Title Priority Date Filing Date
ES479490A Expired ES8303355A1 (es) 1978-04-11 1979-04-10 Procedimiento para la obtencion de nuevos derivados de mer- captoimidazoles.
ES515766A Expired ES8403877A1 (es) 1978-04-11 1982-09-16 Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol.
ES528579A Granted ES528579A0 (es) 1978-04-11 1983-12-30 Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol
ES528580A Granted ES528580A0 (es) 1978-04-11 1983-12-30 Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol
ES528581A Expired ES8505352A1 (es) 1978-04-11 1983-12-30 Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES479490A Expired ES8303355A1 (es) 1978-04-11 1979-04-10 Procedimiento para la obtencion de nuevos derivados de mer- captoimidazoles.

Family Applications After (3)

Application Number Title Priority Date Filing Date
ES528579A Granted ES528579A0 (es) 1978-04-11 1983-12-30 Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol
ES528580A Granted ES528580A0 (es) 1978-04-11 1983-12-30 Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol
ES528581A Expired ES8505352A1 (es) 1978-04-11 1983-12-30 Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol

Country Status (24)

Country Link
US (3) US4461770A (es)
EP (1) EP0004648B1 (es)
JP (1) JPS54135769A (es)
KR (2) KR820002314B1 (es)
AT (1) AT376971B (es)
AU (1) AU532402B2 (es)
CS (1) CS220324B2 (es)
CY (1) CY1302A (es)
DD (1) DD142712A5 (es)
DE (1) DE2963572D1 (es)
DK (1) DK148879A (es)
ES (5) ES8303355A1 (es)
FI (1) FI65066C (es)
GR (1) GR71193B (es)
HK (1) HK87285A (es)
HU (1) HU182018B (es)
IL (1) IL57040A (es)
MY (1) MY8600271A (es)
NO (1) NO148926C (es)
NZ (1) NZ190153A (es)
PL (2) PL125972B1 (es)
PT (1) PT69460A (es)
SU (2) SU1259962A3 (es)
ZA (1) ZA791702B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2823197A1 (de) * 1978-05-24 1979-11-29 Schering Ag Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE2856909A1 (de) * 1978-12-28 1980-07-17 Schering Ag Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3025484A1 (de) * 1980-07-03 1982-02-04 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue imidazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
US4686231A (en) * 1985-12-12 1987-08-11 Smithkline Beckman Corporation Inhibition of 5-lipoxygenase products
US4780470A (en) * 1986-08-19 1988-10-25 Smithkline Beckman Corporation Inhibition of interleukin-1 by monocytes and/or macrophages
FI91754C (fi) * 1986-12-02 1994-08-10 Tanabe Seiyaku Co Analogiamenetelmä lääkeaineena käyttökelpoisen imidatsolijohdannaisen valmistamiseksi
US5955480A (en) * 1996-11-20 1999-09-21 Merck & Co., Inc. Triaryl substituted imidazoles, compositions containing such compounds and methods of use
KR100568438B1 (ko) * 1997-04-24 2006-04-07 오르토-맥네일 파마슈티칼, 인코퍼레이티드 염증성 질환의 치료에 유용한 치환된 이미다졸, 이의 제조방법 및 이를 포함하는 약제학적 조성물
US6040320A (en) * 1997-06-30 2000-03-21 Ortho-Mcneil Pharmaceutical, Inc. 2-substituted imidazoles useful in the treatment of inflammatory diseases
DE19842833B4 (de) 1998-09-18 2005-04-14 Merckle Gmbh 2-Arylalkylthio-imidazole, 2-Arylalkenylthio-imidazole und 2-Arylalkinylthio-imidazole als Entzündungs-Hemmstoffe und Hemmstoffe der Cytokin-Freisetzung
DE10107683A1 (de) 2001-02-19 2002-08-29 Merckle Gmbh Chem Pharm Fabrik 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie
DE10238045A1 (de) * 2002-08-20 2004-03-04 Merckle Gmbh Chem.-Pharm. Fabrik 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie
US8134029B2 (en) * 2002-09-16 2012-03-13 Sunovion Pharmaceuticals Inc. Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
CA2614282A1 (en) 2005-07-06 2007-01-11 Sepracor Inc. Combinations of eszopiclone and trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-napthalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders
WO2007115185A2 (en) * 2006-03-31 2007-10-11 Sepracor Inc. Preparation of chiral amides and amines
EP1894925A1 (en) * 2006-08-24 2008-03-05 Merckle Gmbh Imidazole compounds having an antiinflammatory effect

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2981739A (en) * 1958-01-27 1961-04-25 Diamond Alkali Co Certain alpha-haloaldehyde addition products of ethylenethioureas and process
US3714179A (en) * 1970-09-08 1973-01-30 Searle & Co 1-alkyl-2-furfurylthioimidazoles and congeners
JPS5343958B2 (es) * 1972-07-29 1978-11-24
SE428686B (sv) * 1975-08-11 1983-07-18 Du Pont Forfarande for framstellning av antiinflammatoriskt aktiva imidazoler
US4159338A (en) * 1977-02-09 1979-06-26 E. I. Du Pont De Nemours And Company Antiinflammatory-4,5-dicyclic-2-(substituted thio)-imidazoles and their corresponding sulfoxides and sulfones
DK16778A (da) * 1977-02-09 1978-08-10 Du Pont Imidazolderivater deres anvendelser og fremstilling
LU77703A1 (de) * 1977-07-07 1979-03-26 Ciba Geigy Ag Verfahren zur herstellung von bicyclischen thia-diaza-verbindungen
DE2823197A1 (de) * 1978-05-24 1979-11-29 Schering Ag Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
US4308277A (en) * 1978-08-10 1981-12-29 Ciba-Geigy Corporation 2,4,5-Trisubstituted imidazolines and pharmaceutical compositions containing same
US4175127A (en) * 1978-09-27 1979-11-20 Smithkline Corporation Pyridyl substituted 2,3-dihydroimidazo[2,1-b]thiazoles
DE2856909A1 (de) * 1978-12-28 1980-07-17 Schering Ag Neue imidazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate

Also Published As

Publication number Publication date
ES8504737A1 (es) 1985-05-01
HK87285A (en) 1985-11-15
JPS54135769A (en) 1979-10-22
GR71193B (es) 1983-04-11
KR820002314B1 (ko) 1982-12-17
SU991945A3 (ru) 1983-01-23
NZ190153A (en) 1981-05-15
HU182018B (en) 1983-12-28
ATA266179A (de) 1984-06-15
ES528579A0 (es) 1985-05-01
IL57040A (en) 1984-08-31
DD142712A5 (de) 1980-07-09
ES8504738A1 (es) 1985-05-01
MY8600271A (en) 1986-12-31
AT376971B (de) 1985-01-25
ES528581A0 (es) 1985-05-16
IL57040A0 (en) 1979-07-25
DK148879A (da) 1979-10-12
NO148926B (no) 1983-10-03
US4584310A (en) 1986-04-22
EP0004648A3 (en) 1979-11-14
PL125972B1 (en) 1983-06-30
SU1259962A3 (ru) 1986-09-23
CS220324B2 (en) 1983-03-25
ZA791702B (en) 1980-04-30
US4461770A (en) 1984-07-24
PL214745A1 (es) 1980-06-16
EP0004648B1 (de) 1982-08-25
AU532402B2 (en) 1983-09-29
EP0004648A2 (de) 1979-10-17
PT69460A (en) 1979-05-01
NO148926C (no) 1984-01-11
CY1302A (en) 1985-12-06
US4608382A (en) 1986-08-26
FI65066C (fi) 1984-03-12
JPS6339594B2 (es) 1988-08-05
ES479490A0 (es) 1983-02-01
PL125882B1 (en) 1983-06-30
DE2963572D1 (en) 1982-10-21
ES528580A0 (es) 1985-05-01
ES8505352A1 (es) 1985-05-16
FI791158A (fi) 1979-10-12
AU4599479A (en) 1979-10-18
NO791228L (no) 1979-10-12
ES8403877A1 (es) 1984-04-01
FI65066B (fi) 1983-11-30
ES8303355A1 (es) 1983-02-01
KR820002315B1 (ko) 1982-12-17

Similar Documents

Publication Publication Date Title
MX6046E (es) Procedimiento para la preparacion de 4,5-diaril-2-nitro-imidazoles
ES486786A0 (es) Un procedimiento para la preparacion de carboxialquil-dipep-tidos.
AR219150A1 (es) Procedimiento para preparar nuevos derivados de aminoazucares
ES476994A0 (es) Procedimiento para preparar perhalociclopropanocarboxilatos.
ES486782A0 (es) Un procedimiento para la preparacion de derivados de imida- zol.
ES477509A0 (es) Un procedimiento para la preparacion de derivados de fenil- piperacina.
ES479988A0 (es) Un procedimiento para la preparacion de nuevos derivados - hete rociclicos.
ES508618A0 (es) Procedimiento para la preparacion de derivados de la quino- lina.
ES511260A0 (es) Procedimiento para la obtencion de nuevos derivados de omega-ciano-1, omega-difenil-aza-alcano.
ES515766A0 (es) Procedimiento para la obtencion de nuevos derivados de mercaptoimidazol.
MX6242E (es) Procedimiento para la preparacion de 1,2,3,5,tetrahidroimidazotienopirimidin-2-onas
ES495267A0 (es) Procedimiento para la obtencion de derivados de triazo- lil-a-fluorpinacolilo,acilados de efecto fungicida
ES484382A0 (es) Un procedimiento para la preparacion de nuevos derivados de 2-pirrolidin-metanol.
ES481478A0 (es) Procedimiento para preparar o-metaliloxifenol.
AR221732A1 (es) Procedimiento para la obtencion de 2,6-dialquil-n-(pirazol o 4,5-dihaloimidazolmetil)-2-halo acetanilidas
AR224784A1 (es) Procedimiento para la preparacion de nuevos derivados de 4-amino-2-piperidinoquinazolina
ES482027A0 (es) Un procedimiento para la preparacion de nuevos derivados de fenetilamina.
ES494291A0 (es) Procedimiento para la preparacion de derivados diazoicos.
MX5685E (es) Procedimiento para la preparacion de 4,5-diaril-2-(tio-substituido)-pirrol
MX5933E (es) Procedimiento para la preparacion de 4,5-diciclo-2-(tiosubstituidos)-imidazoles
ES513392A0 (es) Procedimiento para la obtencion de derivados de 2-amino-piridina sustituidos.
ES513169A0 (es) Procedimiento para la obtencion de nuevos derivados de benzazol.
ES494211A0 (es) Procedimiento para la preparacion de nuevos derivados de 10-halogen-e-homo-eburnanos.
AR230835A1 (es) Procedimiento para la obtencion de derivados de 2,1,3-tiadiazin-4-ona-2,2-dioxido
ES488835A0 (es) Procedimiento para la obtencion de nuevos derivados de la piperacina metanimina

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19991108